In mouse models, the administration of TNF-α has been shown to induce cachexia [13], however TNF inhibition alone was not sufficient to reverse the cachexia phenotype, indicating the complex underlying pathophysiology of the syndrome [14]. The gene discussed is TNF; the disease is Cachexia.